Ionis Pharmaceuticals | IONS - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Arrowhead Research USD 75.25M 1.52M 2026-06
Astellas Pharma JPY 482.54B 38.28B 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Exelixis USD 608.03M 17.17M 2026-06
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Ionis Pharmaceuticals USD 265M 22M 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Omeros USD -33.16M 18.52M 2024-06
OPKO Health USD 45.76M 755K 2026-03
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pfizer USD -248M 11.29B 2026-06
Pharma Mar EUR 44.87M 5.63M 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Qiagen NV USD 340.39M 30.78M 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tilray USD 57.47M 10.16M 2025-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03